Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes.

Kim, Yundeok; Kim, In-Ho; Kim, Hyeong Joon; Park, Silvia; Lee, Kyoo-Hyung; Kim, Soo Jeong; Lee, Jung-Hee; Kim, Dae-Young; Yoon, Sung-Soo; Kim, Yeo-Keoung; Jang, Jun Ho; Park, Seon Yang; Ahn, Jae-Sook; Cheong, Chul Won; Lee, Je-Hwan; Cheong, June-Won

Kim, Yundeok; Kim, In-Ho; Kim, Hyeong Joon; Park, Silvia; Lee, Kyoo-Hyung; Kim, Soo Jeong; Lee, Jung-Hee; Kim, Dae-Young; Yoon, Sung-Soo; Kim, Yeo-Keoung; Jang, Jun Ho; Park, Seon Yang; Ahn, Jae-Sook; Cheong, Chul Won; Lee, Je-Hwan; Cheong, June-Won.

Affiliation

Kim Y; Severance Hospital, Yonsei University College of Medicine, 250 Seongsan-ro, Seodaemun-gu, Seoul, 120-752, Korea.

Int J Hematol ; 99(5): 635-43, 2014.

Article de En | MEDLINE | ID: mdl-24648120

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Azacitidine / Syndromes myélodysplasiques / DNA (cytosine-5-)-methyltransferase / Antimétabolites antinéoplasiques Type d'étude: Diagnostic_studies / Observational_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Int J Hematol Sujet du journal: HEMATOLOGIA Année: 2014 Type de document: Article Pays de publication: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google